Andremont O. et al.
Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers.
Intensive Care Med. 2020 Apr 20

Jouvin-Marche E. et al.
French research strategy to tackle antimicrobial resistance.
Lancet 2020 Apr 18

Caméléna F. et al.
Genomic characterization of 16S rRNA methyltransferase-producing Escherichia coli isolates from the Parisian area, France.
J. Antimicrob. Chemother. 2020 Apr 16

Sallard E. et al.
Type 1 interferons as a potential treatment against COVID-19.
Antiviral Res. 2020 Apr 7

Lescure FX. et al.
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
Lancet Infect. Dis. 2020 Mar 27

Madelain V. et al.
Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials.
CPT Pharmacometrics Syst. Pharmacol. 2020 Mar 20

Choudhury A. et al.
CRISPR/Cas9 recombineering-mediated deep mutational scanning of essential genes in Escherichia coli.
Mol. Syst. Biol. 2020 Mar 16

Marcelin AG. et al.
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients.
J. Antimicrob. Chemother 2020 Mar 10

Cointe A. et al.
Escherichia coli O80 hybrid pathotype strains producing Shiga toxin and ESBL: molecular characterization and potential therapeutic options
J. Antimicrob. Chemother. 2020 Mar 1

Charpentier C. et al.
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial)
J. Antimicrob. Chemother. 2020 Feb 24

Riglet F. et al.
Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM. AAPS J. 2020 Feb 19

Peiffer-Smadja N. et al.
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?
Clin. Microbiol. Infect. 2020 Feb 12

Hobson CA et al.
Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam
Sci. Rep. 2019 Jan 17

Tubiana S. et al.
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long term disability and determinants of outcome in a multicentre prospective cohort
Clin. Microbiol. Infect. 2019 Jan 9

Le Hingrat Q. et al.
Genetic variability of Long Terminal Repeat region between HIV-2 groups impacts transcriptional activity
J. Virol. 2019 Jan 8

Maataoui N. et al.
Increased risk of acquisition and transmission of ESBL-producing Enterobacteriaceae in malnourished children exposed to amoxicillin
J. Antimicrob. Chemother. 2019 Dec 10

Jacquier H. et al.
Benefits of Polymerase Chain Reaction Combined With Culture for the Diagnosis of Bone and Joint Infections: A Prospective Test Performance Study
Open Forum Infect. Dis. 2019 Dec 2

Mentré F. et al.
Pharmacometrics and Systems Pharmacology 2030
Clin Pharmacol Ther. 2019 Nov 23

Vaillant L. et al.
Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey
Antimicrob Resist Infect Control. 2019 Nov 12

Ibn Saied W. et al.
Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome
J Infect. 2019 Nov 2

Visseaux B. et al.
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
J. Antimicrob. Chemother. 2019 Oct 22

Saint-Lu N. et al.
DAV131A protects hamsters from lethal Clostridioides difficile infection induced by fluoroquinolones
Antimicrob Agents Chemother. 2019 Oct 21

Buetti N. et al.
Short-term dialysis catheter versus central venous catheter infections in ICU patients: a post hoc analysis of individual data of 4 multi-centric randomized trials
Intensive Care Med. 2019 Oct 17

Birgy A. et al.
Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017
J. Antimicrob. Chemother. 2019 Oct 16

Eholie S. et al.
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study. Lancet HIV 2019 Oct 7

Tubiana S. et al.
Attitudes, knowledge, and willingness to be vaccinated against seasonal influenza among patients hospitalized with Influenza-Like-Illness: impact of diagnostic testing
Hum. Vaccin. Immunother. 2019 Oct 7

Microbial_genomicsMahérault A-C. et al.
Advantage of the F2:A1:B- IncF pandemic plasmid over IncC plasmids in in vitro acquisition and evolution of blaCTX-M gene-bearing plasmids in Escherichia coli
Antimicrob. Agents Chemother. 2019 Sep 23

Microbial_genomicsMorvan AC. et al.
Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care-an analysis of the OUTCOMEREA database
Crit. Care. 2019 Sep 6

m_jac_74_6coverGhalayini M. et al.
Long-term evolution of the natural isolate of Escherichia coli 536 in the mouse gut colonized after maternal transmission reveals convergence in the constitutive expression of the lactose operon
Mol Ecol 2019 Sep 4

m_jac_74_6coverMandelbrot L. et al.
Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model
PLoS One 2019 Aug 13

m_jac_74_6coverBranger C. et al.
Specialization of small non-conjugative plasmids in Escherichia coli according to their family types
Microb. Genom. 2019 Aug 7

m_jac_74_6coverDufour N. et al.
Phage Therapy of pneumonia is not associated with an overstimulation of the inflammatory response compared to antibiotic areatment in mice
Antimicrob. Agents Chemother. 2019 Jul 25

m_jac_74_6coverBurdet C. et al.
Impact of antibiotic gut exposure on the temporal changes in microbiome diversity
Antimicrob. Agents Chemother. 2019 Jul 15

m_jac_74_6coverCouce A. and Tenaillon O.
Mutation bias and GC content shape antimutator invasions
Nat. Commun. 2019 Jul 15

m_jac_74_6coverLoubet P. et al.
Community-acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT scan indication
Clin. Microbiol. Infect. 2019 Jul 5

m_jac_74_6coverCastain L. et al.
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations
J. Antimicrob. Chemother. 2019 Jul 1

AACBirgy A. et al.
Independent host factors and bacterial genetic determinants of the emergence and dominance of Escherichia coli sequence type 131 CTX-M-27 in a community pediatric cohort study
Antimicrob. Agents Chemother. 2019 Jun 24

AACKieffer N. et al.
mcr-9, an inducible gene encoding an acquired phosphoethanolamine transferase in Escherichia coli, and its origin
Antimicrob. Agents Chemother. 2019 Jun 17

m_jac_74_6coverPerozziello A. et al.
Prescribers’ experience and opinions on antimicrobial stewardship programmes in hospitals: a French nationwide survey
J. Antimicrob. Chemother. 2019 Jun 5

m_jac_74_6coverSeurat J. et al.
Robust designs accounting for model uncertainty in longitudinal studies with binary outcomes
Stat. Methods Med. Res. 2019 Jun 5.

AACBurdet C. et al.
Ceftriaxone and cefotaxime have similar effects on the intestinal microbiota in human volunteers treated by standard-dose regimens
Antimicrob. Agents Chemother. 2019 May 24.